ММВБ 3 837 0,4%  Nasdaq 14 272 0,1%  Биткойн 32 596 -3,1%  USD/RUB 72,5595 -0,1% 
РТС 1 666 1,3%  S&P500 4 242 -0,1%  Нефть 75,2 -0,3%  EUR/RUB 86,5110 -0,1% 
Dow 33 874 -0,2%  FTSE100 7 074 -0,2%  Золото 1 776 -0,2%  EUR/USD 1,1924 0,0% 

Helix Biopharma Corp. - Профиль

Helix BioPharma Corp. is an immuno-oncology company, which develops products for the treatment and prevention of cancer. It focuses on the medicines in the field of immuno-oncology based on its proprietary technological platform DOS47 and Tumor Defence Attackers CAR-T. The company was founded on July 31, 1995 and is headquartered in Richmond Hill, Canada.

Акционеры

Название Доля (%)
Freefloat98,79
CAIAC Fund Management AG19,83
Jerzy Wilczewski10,98
Slawomir Majewski, MD, PhD1,26

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент